GLOBAL RAT MODEL MARKET FORECAST 2019-2027

[vc_row][vc_column width=”3/4″][vc_message]The global rat model market is anticipated to grow at a CAGR of 8.08% between 2019 and 2027 to generate revenue of $XX million by 2027. Rat models have always been suitable and affordable in medical study and in pharmaceutical as well as industrial biotechnology research which covers the fields of drug discovery, toxicology and preclinical studies.[/vc_message][vc_row_inner layout=”boxed” el_class=”an-report-custom-heading” css=”.vc_custom_1505383461536{margin-bottom: 32px !important;}”][vc_column_inner width=”1/6″][vc_single_image image=”7478″][/vc_column_inner][vc_column_inner width=”5/6″][vc_column_text]

GLOBAL RAT MODEL MARKET FORECAST 2019-2027

Global Rat Model Market  by Rat Type (Inbred, Genetically Engineered Rats, Surgically Modified Rats, Hybrid, Outbred, Immune-deficient)  by Application (Diabetes, Toxicology, Oncology, Immunology & Inflammation, Other Application)  by Component (Technology, Services, Rat Care Products) by Geography.

Request free sample[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_tta_tabs style=”tab_style3″ active_section=”1″][vc_tta_section title=”Report Summary” tab_id=”1475833031039-7bedc447-8e15″][vc_column_text]

The global rat model market is anticipated to grow at a CAGR of 8.08% between 2019 and 2027 to generate revenue of $XX million by 2027. Rat models have always been suitable and affordable in medical study and in pharmaceutical as well as industrial biotechnology research which covers the fields of drug discovery, toxicology and preclinical studies. The following factors primarily drive the rat model market:

• Enhancement in genome editing
• Growing availability in rat transgenic
• Swelling pharmaceutical and biotechnology corporations R&D

To know more about this report, request a free sample copy

The important drivers increasing growth in the global rat model market are the enhancement in genome editing and the growing availability of transgenic rat. The innovating step in genome editing is the advent of the Cas9 system or CRISPR that accounts for increased demand among the researchers and speeding up of further exploration. The major benefit of using a rat model over mice is the close similarity of rat’s physiology to that of the humans.

The applications of rat model market are used extensively for various purposes. Diabetes is a chronic disease which was featured by a lack of insulin and ensuing hyperglycemia. Toxicology is a field of medicine, chemistry and biology that deals with the study of potential toxins leaving the system and subsequent expression due to their presence. In research, more than 100 thousands of rats are approximately used every year for the experiments for obtaining the expected output. Oncology is a branch of medicine which deals with the diagnoses, prevention and treatment of cancer. Immunology is a branch of biology which carries out the study of the immune system of organisms. The increasing demand of the genome market is one of the major factors which rising the subsequent growth of the market for immunology and inflammation. Obesity, HIV-AIDs, heart disease, etc. are some of the major diseases which are widening the scope of the market for rat model globally. The increasing obesity cases are one major cause for the growth of demand of rat model in research. Obesity is a type of disorder that occurs due to a severe increase in body weight.

Unethical practices of animals model systems in research and fluctuating rules and regulation on animal testing are the major factors hindering the rat model market. For instance, the Animal Ethics Committees decides whether the research on an animal can be valid or not in Australia. AEC follows code for the wellbeing of the animal in research. The varying rules and regulation on animal testing hamper the growth of the rat model market to a greater extent.

The global rat model market segments include rat types, applications and components.

Rat types are sub-segmented into:

• Inbred
• Genetically engineered rats
• Surgically modified rats
• Hybrid
• Outbred
• Immune-deficient

Applications are sub-segmented into:

• Diabetes
• Toxicology
• Oncology
• Immunology & inflammation
• Other application

Components are sub-segmented into:

• Technology
  • Nuclear transferase
  • Microinjection
  • Embryonic stem cell injection
  • Other technology
• Services
• Rat care products
  • Feed
  • Bedding
  • Cages
  • Other rat care products

This report covered the present market conditions and the growth prospects of the global rat model market for 2019-2027 and considered the revenue generated through the sales of the rat model for rat types, applications and components to calculate the market size by considering 2018 as the base year.

Geographically, the global rat model market has been segmented by four major regions, which include:

• North America Rat Model Market : The United States & Canada
• Asia-Pacific Rat Model Market : China, India, Japan, Australia, South Korea & Rest of APAC
• Europe Rat Model Market : The United Kingdom, France, Germany, Italy, Spain & Rest of Europe
• Rest of World: Latin America & the Middle East and Africa

The rat model market in North America is expected to hold the largest share by 2027 because of the possibilities of rising demand for rats in the pre-clinical animal trial studies by contract research organizations and major pharmaceutical companies like Merck & Co., Roche, Novartis, etc. within the regional countries. Expectedly, the presence of a large number of contractual research organizations has also attributed to the growth of regional countries.

On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the rat model market. The Asia Pacific is a native place to numerous developing economies such as China, India and Japan that provide better opportunities for the global rat model market to grow over the projected period. Supportive R&D incentive schemes for CROs and pharmaceutical complies with the regional countries such as India, China and Australia and the booming growth of the pharmaceutical sector is fuelling the growth of the Asia Pacific rat model market.

The rat model market is segmented on rat types which are sub-divided into inbred, genetically engineered rats, surgically modified rats, hybrid and outbred. The market is also segmented based on a component which is further sub-divided into technology, services and rat care products. Inbred rats are those which have homogenous genes and allele. Genetically engineered rats are the ones whose genetic material has been transformed through genetic engineering techniques such as a genetically engineered organism. Hybrid rats are those rats which are produced by mating two inbred strains, crossed in the same direction. Outbred rats are the most common animals used in drug safety testing at this time. Immune deficient rats are the laboratory rats created from a strain with a genetic mutation that results in the deteriorated or absent thymus in the immune system. The technological advancement in genetic testing, for instance, like the Zinc finger nucleases (ZFN) is increasing the demand for technology in rat models. Rat care products can be classified as necessary products to support the rat care models. This segment can be classified as feed, cages, bedding and other rat care products.

The major market players of the global rat model market are:

• Charles River Laboratories Inc.
• Sage Labs Inc. (Acquired By Horizon Discovery Group PLC)
• Genoway S.A.
• Taconic Biosciences
• Transposagen Biopharmaceuticals Inc.

The company profiles cover analysis of important market players. Charles River Laboratories International Inc. specialized in a wide variety of clinical laboratory services and pre-clinical services for the biotechnology, pharmaceutical, medical device industries. Transposagen Biopharmaceuticals Inc. is a privately-held biotechnology company which has to commercialization for the construction of rodent models of disease by gene editing technology.

Key findings of the global rat model market are:

• Outbred rat type holds the major share in the rat model market
• Oncology is the fastest growing application
• Rat care products are significantly growing

[/vc_column_text][/vc_tta_section][vc_tta_section title=”Table of Contents” tab_id=”1475833031119-d3116813-2493″][vc_column_text]

1. RESEARCH SCOPE
   • STUDY GOALS
   • SCOPE OF THE MARKET STUDY
   • WHO WILL FIND THIS REPORT USEFUL?
   • STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
   • SOURCES OF DATA
     • SECONDARY DATA
     • PRIMARY DATA
   • TOP-DOWN APPROACH
   • BOTTOM-UP APPROACH
   • DATA TRIANGULATION
3. EXECUTIVE SUMMARY
   • MARKET SUMMARY
   • KEY FINDINGS
     • OUTBRED RAT TYPE HOLDS THE MAJOR SHARE IN THE RAT MODEL MARKET
     • ONCOLOGY IS THE FASTEST GROWING APPLICATION
     • RAT CARE PRODUCTS ARE SIGNIFICANTLY GROWING

4. MARKET DYNAMICS
   • MARKET SCOPE & DEFINITION
   • MARKET DRIVERS
     • ENHANCEMENT IN GENOME EDITING
     • GROWING AVAILABILITY IN RAT TRANSGENIC
     • SWELLING PHARMACEUTICAL AND BIOTECHNOLOGY CORPORATIONS R&D
   • MARKET RESTRAINTS
     • PRACTICE OF ANIMALS IN RESEARCH IS CONSIDERED UNETHICAL
     • FLUCTUATING RULES AND REGULATION ON ANIMAL TESTING
     • USE OF ZEBRAFISH IN RESEARCH IS THE GROWING MODEL
     • IN VITRO AND ALTERNATIVE TESTING TECHNIQUES MODELS FOR RESEARCH
   • MARKET OPPORTUNITIES
     • PERSONALIZED MEDICINE ESTABLISHED TO SURGE DEMAND
     • ESCALATION IN MONOCLONAL ANTIBODY CREATION
   • MARKET CHALLENGES
     • HIGHLY EXPENSIVE RAT MODEL

5. MARKET BY RAT TYPE
   • INBRED
   • GENETICALLY ENGINEERED RATS
   • SURGICALLY MODIFIED RATS
   • HYBRID
   • OUTBRED
   • IMMUNE-DEFICIENT
6. MARKET BY APPLICATION
   • DIABETES
   • TOXICOLOGY
   • ONCOLOGY
   • IMMUNOLOGY & INFLAMMATION
   • OTHER APPLICATION
7. MARKET BY COMPONENT
   • TECHNOLOGY
     • NUCLEAR TRANSFERASE
     • MICROINJECTION
     • EMBRYONIC STEM CELL INJECTION
     • OTHER TECHNOLOGY
   • SERVICES
   • RAT CARE PRODUCTS
     • FEED
     • BEDDING
     • CAGES
     • OTHER RAT CARE PRODUCTS

8. KEY ANALYTICS
   • PORTER’S FIVE FORCE MODEL
     • THREAT OF NEW ENTRANTS
     • THREAT OF SUBSTITUTE PRODUCT
     • BARGAINING POWER OF BUYERS
     • BARGAINING POWER OF SUPPLIERS
     • INTENSITY OF COMPETITIVE RIVALRY
   • VALUE CHAIN ANALYSIS
   • REGULATORY FRAMEWORK
   • KEY BUYING CRITERIA
     • HIGH ACCURACY
     • HIGH EFFICACY
     • QUALITY OF OPERATING PROCEDURE
     • PRICE
   • OPPORTUNITY MATRIX
9. GEOGRAPHICAL ANALYSIS
   • NORTH AMERICA
     • THE UNITED STATES
     • CANADA
   • EUROPE
     • THE UNITED KINGDOM
     • FRANCE
     • GERMANY
     • SPAIN
     • ITALY
     • REST OF EUROPE
   • ASIA PACIFIC
     • INDIA
     • CHINA
     • JAPAN
     • SOUTH KOREA
     • AUSTRALIA
     • REST OF ASIA PACIFIC
   • REST OF WORLD
     • LATIN AMERICA
     • MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • BIOMERE
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
      • CHARLES RIVER LABORATORIES INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • CLEA JAPAN
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • CYAGEN BIOSCIENCES INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
      • ENVIGO
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • GENOWAY S. A.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • HERA BIOLABS INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • JANVIER LABS
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
      • LABORATORY CORPORATION OF AMERICA HOLDINGS
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • ONCODESIGN S.A.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVE
      • SAGE LABS INC. (ACQUIRED BY HORIZON DISCOVERY GROUP PLC.)
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • TACONIC BIOSCIENCES
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • TRANSPOSAGEN BIOPHARMACEUTICALS INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • TRANSVIRAGEN INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
      • VIVO BIOTECH LTD.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES

 

 

[/vc_column_text][/vc_tta_section][vc_tta_section title=”Segmentation” tab_id=”1475833178732-b3723960-5e6b”][vc_column_text]

1. MARKET BY RAT TYPE
   • INBRED
   • GENETICALLY ENGINEERED RATS
   • SURGICALLY MODIFIED RATS
   • HYBRID
   • OUTBRED
   • IMMUNE-DEFICIENT
2. MARKET BY APPLICATION
   • DIABETES
   • TOXICOLOGY
   • ONCOLOGY
   • IMMUNOLOGY & INFLAMMATION
   • OTHER APPLICATION
3. MARKET BY COMPONENT
   • TECHNOLOGY
     • NUCLEAR TRANSFERASE
     • MICROINJECTION
     • EMBRYONIC STEM CELL INJECTION
     • OTHER TECHNOLOGY
   • SERVICES
   • RAT CARE PRODUCTS
     • FEED
     • BEDDING
     • CAGES
     • OTHER RAT CARE PRODUCTS

4. GEOGRAPHICAL ANALYSIS
   • NORTH AMERICA
     • THE UNITED STATES
     • CANADA
   • EUROPE
     • THE UNITED KINGDOM
     • FRANCE
     • GERMANY
     • SPAIN
     • ITALY
     • REST OF EUROPE
   • ASIA PACIFIC
     • INDIA
     • CHINA
     • JAPAN
     • SOUTH KOREA
     • AUSTRALIA
     • REST OF ASIA PACIFIC
   • REST OF WORLD
     • LATIN AMERICA
     • MIDDLE EAST AND AFRICA

 

[/vc_column_text][/vc_tta_section][vc_tta_section title=”Request Free Sample” tab_id=”1475833280868-15fab1a7-920c”][vc_column_text]To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.[/vc_column_text][vc_empty_space height=”50px”]

[/vc_tta_section][/vc_tta_tabs][/vc_column][vc_column width=”1/4″][vc_widget_sidebar sidebar_id=”reportpagewidget1″ el_class=”sidebar”][vc_row_inner layout=”boxed” el_class=”an-report-cart”][vc_column_inner][vc_raw_html css=”.vc_custom_1485151257789{padding-top: 20px !important;}”]JTNDaDQlMjBjbGFzcyUzRCUyMndpZGdldC10aXRsZSUyMiUzRUNob29zZSUyMExpY2Vuc2UlMjBUeXBlJTNDJTJGaDQlM0U=[/vc_raw_html][vc_column_text]

• Single user licence – $2,900.00
• Corporate licence – $4,500.00

•  Single user licence – $2,900.00
•  Corporate licence – $4,500.00

Buy Now Checkout Added to cart

[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_widget_sidebar sidebar_id=”sidebar_4″ el_class=”an-report-widget2″][vc_widget_sidebar sidebar_id=”reportpagewidget3″ el_class=”an-report-widget3″][/vc_column][/vc_row][vc_row layout=”boxed” el_class=”an-reports-related-reports”][vc_column][vc_column_text][/vc_column_text][/vc_column][/vc_row]